1. Inhibition of S6K1 enhances dichloroacetate-induced cell death
    Sung-Eun Hong et al, 2015, Journal of Cancer Research and Clinical Oncology CrossRef
  2. Dichloroacetate Enhances Adriamycin-Induced Hepatoma Cell Toxicity In Vitro and In Vivo by Increasing Reactive Oxygen Species Levels
    Yunhai Dai et al, 2014, PLoS ONE CrossRef
  3. The presence of wild type p53 in hematological cancers improves the efficacy of combinational therapy targeting metabolism
    Nerea Allende-Vega et al, 2015, Oncotarget CrossRef
  4. Effect of sodium dichloroacetate on apoptotic gene expression in human leukemia cell lines
    Jagoda Abramek et al, 2019, Pharmacological Reports CrossRef
  5. TRAIL restores DCA/metformin-mediated cell death in hypoxia
    Sung-Eun Hong et al, 2016, Biochemical and Biophysical Research Communications CrossRef
  6. The HIV Protease Inhibitor Nelfinavir Down-Regulates RET Signaling and Induces Apoptosis in Medullary Thyroid Cancer Cells
    Yevgeniya Kushchayeva et al, 2014, The Journal of Clinical Endocrinology & Metabolism CrossRef
  7. Targeting HIF-1α is a prerequisite for cell sensitivity to dichloroacetate (DCA) and metformin
    Sung-Eun Hong et al, 2016, Biochemical and Biophysical Research Communications CrossRef
  8. Cellular acidification as a new approach to cancer treatment and to the understanding and therapeutics of neurodegenerative diseases
    Salvador Harguindey et al, 2017, Seminars in Cancer Biology CrossRef
  9. Necrosis of cervical carcinoma by dichloroacetate released from electrospun polylactide mats
    Daxing Liu et al, 2012, Biomaterials CrossRef
  10. The metabolism of cells regulates their sensitivity to NK cells depending on p53 status
    Sana Belkahla et al, 2022, Scientific Reports CrossRef
  11. Emerging role of metabolic reprogramming in the immune microenvironment and immunotherapy of thyroid cancer
    Shouhua Li et al, 2025, International Immunopharmacology CrossRef
  12. Anti-Glycolytic Drugs in the Treatment of Hepatocellular Carcinoma: Systemic and Locoregional Options
    Miles Pourbaghi et al, 2023, Current Oncology CrossRef